Jolanta Zuwala-Jagiello1, Monika Pazgan-Simon2, Eugenia Murawska-Cialowicz3, Krzysztof Simon2. 1. Department of Pharmaceutical Biochemistry, Wroclaw Medical University, Wroclaw, Poland jolanta.zuwala-jagiello@umed.wroc.pl. 2. Infectious Disease Department, Division of Infectious Disease and Hepatology Wroclaw Medical University, Wroclaw, Poland. 3. Department of Physiology and Biochemistry, University of Physical Education, Wroclaw, Poland.
Abstract
BACKGROUND/AIM: Type 2 diabetes mellitus (DM) frequently occurs in patients with chronic hepatitis C (CHC) and is associated with atherosclerosis, in which circulating microparticles (MPs) play an important role. We asked whether the presence of DM affects endothelial-derived (EMPs) and platelet-derived microparticles (PMPs) levels; and whether MPs levels associate with biomarkers of inflammation and oxidative stress in patients with CHC. MATERIALS AND METHODS: Overall, 136 patients were enrolled in the study, 86 CHC patients (41 with DM with moderate glycemic control), 20 outpatients with DM and 30 controls. Circulating MPs were phenotyped by flow cytometry. RESULTS: When the MPs levels were analyzed individually in CHC patients, there was a positive association of plasma apoptotic MPs with oxidative stress markers. We report a hitherto undescribed relationship between diabetes prevalence and apoptotic MPs-associated inflammation in patients with CHC. CONCLUSION: The presence of apoptotic MPs in the plasma of CHC patients, with increased levels being found in patients with DM and moderate glycemic control was herein demonstrated. The simultaneous monitoring of plasma apoptotic MPs, oxidative stress markers and inflammatory biomarkers can be helpful for the cardiovascular disease control in diabetic patients with CHC. Copyright
BACKGROUND/AIM: Type 2 diabetes mellitus (DM) frequently occurs in patients with chronic hepatitis C (CHC) and is associated with atherosclerosis, in which circulating microparticles (MPs) play an important role. We asked whether the presence of DM affects endothelial-derived (EMPs) and platelet-derived microparticles (PMPs) levels; and whether MPs levels associate with biomarkers of inflammation and oxidative stress in patients with CHC. MATERIALS AND METHODS: Overall, 136 patients were enrolled in the study, 86 CHCpatients (41 with DM with moderate glycemic control), 20 outpatients with DM and 30 controls. Circulating MPs were phenotyped by flow cytometry. RESULTS: When the MPs levels were analyzed individually in CHCpatients, there was a positive association of plasma apoptotic MPs with oxidative stress markers. We report a hitherto undescribed relationship between diabetes prevalence and apoptotic MPs-associated inflammation in patients with CHC. CONCLUSION: The presence of apoptotic MPs in the plasma of CHCpatients, with increased levels being found in patients with DM and moderate glycemic control was herein demonstrated. The simultaneous monitoring of plasma apoptotic MPs, oxidative stress markers and inflammatory biomarkers can be helpful for the cardiovascular disease control in diabeticpatients with CHC. Copyright
Authors: Michaela Diamant; Rienk Nieuwland; Renée F Pablo; Augueste Sturk; Jan W A Smit; Jasper K Radder Journal: Circulation Date: 2002-11-05 Impact factor: 29.690
Authors: Felix Jansen; Xiaoyan Yang; Bernardo S Franklin; Marion Hoelscher; Theresa Schmitz; Jörg Bedorf; Georg Nickenig; Nikos Werner Journal: Cardiovasc Res Date: 2013-01-22 Impact factor: 10.787